PTPRC and neoplasm: In the 1G11 group, the rate of CD8+/CD45+ in tumor tissues showed an increasing trend compared with the mIgG control, (Fig. 4D), and the rates of CD3+/CD45+ and CD4+/CD45+ increased significantly (Fig. 4D).